In this issue
Research
Role of dual and triple fixed-dose combination inhalers in the treatment of chronic obstructive pulmonary diseaseSubscription
A review of the current evidence, including the safety and efficacy of dual and triple-combination inhalers for the treatment of stable COPD, and their place in therapy.
Insight
How pharmacists can help prevent an ‘opioid crisis’ developing in the UKSubscription
Pharmacy must demonstrate that it has the knowledge and skills to support people to use opiods safely and effectively.
CPD article
Management of post-operative nausea and vomiting in adultsSubscription
The evidence base supporting pharmacological and non-pharmacological interventions for nausea and vomiting after surgery.
Short communications
Empirical antibiotic treatment of sepsis: impact of specialist pharmacist reviewSubscription
Guidelines from the National Institute for Health and Care Excellence recommend that empirical antibiotic courses initiated in hospital inpatients should be reviewed within 72 hours[1]; ...
Prescribing and deprescribing sodium valproate: implications for pharmacy practiceSubscription
Children exposed to valproate in utero are at a high risk of serious developmental disorders (30–40% risk) and congenital malformations (10% risk). Valproate is now contraindicated in pregnancy for all indications, except for the treatment of epilepsy in the absence of a suitable alternative
